Doktor axborotnomasi 2024, №3 (115)

Тема статьи

FEATURES OF THE IMMUNE SYSTEM IN ENDOMETRIAL HYPERPLASIA IN THE PERIMENOPAUSAL PERIOD (63-68)

Авторы

N. О. Nurkhanova

Учреждение

Bukhara state medical institute, Bukhara, Uzbekistan

Аннотация

This article discusses the immunological features of the development of endometrial hyperplasia in women in the perimenopausal period. Markers of proliferation and apoptosis and pro-inflammatory cytokines in the blood serum were examined in women. They were divided into two groups (group 1 - HE, group 2 - recurrent HE turning to PHE), and it was revealed that in both groups of women, immunological changes were unidirectional, but more pronounced immunological changes were observed in the second group. Common properties for the studied groups were a de crease in the level of CD25+ and CD95+ cells and a significant increase in the level of IL-1β, IL-6, TNFα and a de crease in IL-2. Based on the results obtained, it cannot be unequivocally stated that the detected changes are directly related to the local processes of the reproductive organs in women with GE and possibly reflect the premorbid back ground of the patients. All this dictates the need for additional tests to study local immunity.

Ключевые слова

GE, PGE, CD25+, CD95+, IL-1β, IL-2, IL6, TNFα.

Литературы

1. A. N. Strizhakov. Issues of gynecology, obstetrics and perinatology / Moscow: Dynasty, 2017. – Volume 6, No. 3. – 97 p. 2. Burlev V.A., Olovsson M. Angiogenesis of ectopic endometrium (results of international cooperation). In: Modern technologies in the diagnosis and treatment of gynecological diseases. M., 2016; 100-1. 3. Gavrilova T.Yu., Adamyan L.V., Vasilenko I.A. and others. Some features of the morphofunctional state of immu nocompetent cells in patients with adenomyosis. Materials of VII Ross, Mother and Child Forum. M., 2015; 349 50. 4. Gusaeva Kh.Z., Marchenko I.A. and others. Some pathophysiological mechanisms of benign processes of the uter us. Proceedings of the International Congress on Reproductive Medicine. M., 2016; 54. 5. D. I. Sokolov, P. G. Kondratyeva, M. I. Yarmolinskaya. The content of chemokines and cytokines in the peritoneal fluid of patients with external genital endometriosis of varying severity // Medical Immunology. – 2017. – T. 9, No. 1. – P. 85-90. 6. Pashkov, V. M. Modern ideas about the etiology and pathogenesis of genital endometriosis / V. M. Pashkov, V. A. Lebedev // Issues of gynecology, obstetrics and perinatology. – 2017. – T. 6, No. 3. – P. 52-61 7. T. U. Aripova, D. A. Musakhodzhaeva, G. Z. Eshimbetova. Features of the state of the immune system of women with genital endometriosis // Russian Journal of Allergology. – 2018. – T. 15, No. S1-2. – pp. 13-15. 8. Faizullaeva N.Ya., Nuraliev N.A., Yuldashev M.A. Immunological reactivity of women with cervical intraepitheli al neoplasia of the cervix // News of dermatovenerology and reproductive health, Central Asian scientific and practical journal. - Russia, 2013. - No. 3A. - P.98-99. 9. Yangieva G.Z., Kattakhodzhaeva M.Kh., Faizullaeva N.Ya. Clinical characteristics of sick women with cervical diseases // News of dermatovenerology and reproductive health, Central Asian scientific and practical journal. - Russia, 2013. - No. 3B. - P.58-59. 10. Bruner-Tran KL, Zhang Z., Eisenberg E., Winneker RC, Osteen KG Down-regulation of endometrial matrix met alloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, Tanaproget . J Clin Endocrinol Metab 2016; 91(4): 1554-60. 11. Bulun SE, Cheng YH, Yin P, et al. Progesterone resistance in endometriosis: Link to failure to metabolize estradi ol. Mol Cell Endocrinol 2016; 248(1-2): 94-103. 12. Bourlev V., Larsson A., Olovsson M. Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis. Am J Obstet Gynecol 2016; 194(3): 755-9. 13. Chen JL, Lin QH, Fang XL, Tao GS, Huang FY Effect of progesterone on the secretion of matrix metalloprotein ase-2 and matrix metalloproteinase-9 in human ectopic endometrial stromal cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2015; 30(3): 307-11. 14. Di Blasio AM, Di Francesco S., Abbiati A., Vigano P. Genetics of endometriosis. Minerva Ginecol 2015; 57(3): 225-36. 15. Girling JE, Rogers PA Recent advances in endometrial angiogenesis research. Angiogenesis 2005; 8(2): 89-99. Epub 2015 Oct 7. 16. Guo SW Association of endometriosis risk and genetic polymorphisms involving sex steroid biosynthesis and their receptors: a meta-analysis. Gynecol Obstet Invest 2016; 61(2): 90-105. EDN: LNBIER 17. Huber A., Keck CC, Hefler LA, et al. Ten estrogen-related polymorphisms and endometriosis: a study of multiple gene-gene interactions. Obstet Gynecol 2015; 106(5 Pt 1): 1025-31. EDN: LXLTJV 18. Hudelist G., Keckstein J., Czerwenka K., et al. Estrogen receptor beta and matrix metalloproteinase 1 are coex pressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertil Steril 2015; 84 (Suppl 2): 1249-56. 19. Kim KH, Kwak JY, Shin BS, et al. Nitric oxide inhibition of the proliferation of ovarian endometriotic stromal cells in vitro. J Reprod Med 2015; 50(9): 707-14. 20. Laschke MW, Elitzsch A., Vollmar V., Vajkoczy P., Menger MD Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 2016; 21 (1): 262-8. 21. Lin YJ, Lai MD, Lei HY, Wing LY Neutrophils and macrophages promote angiogenesis in the early stage of en dometriosis in a mouse model. Endocrinology 2016; 147(3): 1278-86. 22. Nurkhanova N.O. Assessment of the risk of endometrial hyperplasia in the perimenopausal period. / International Journal of Advanced Research in Engineering and Applied Sciences, 2022. Vol. 11.No. 6. R. 8-15. https:// garph.co.uk/IJAREAS/June2022/2.pdf 23. Prip C.M., Stentebjerg M., Bennetsen M.H., Petersen L.K., Bor P. Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study // PLoS ONE. – 2022. – Vol. 17(4). – Art. ID: e0266339. https://doi.org/10.1371/journal.pone.0266339 24. Shan K., Lian-Fu Z., Hui D., et al. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China. Mol Hum Reprod 2020; 12(1): 35-9. EDN:ITLUZL 25. Zaripova D.Ya., Tuksanova D.I., Negmatullaeva M.N. Features of the perimenopausal transition in obese women. News of dermatovenerology and reproductive health. No. 1-2.2020 pp. 39-42.